We therefore finally explored in a preliminary statistical analysis whether combined analysis of PSP/reg1A and hsCRP serum levels could increase the ability of the individual serum markers to discriminate HNF1A from HNF4A patients. The gene discussed is HNF4A; the disease is supranuclear palsy, progressive, 1.